BG51159A3 - Process for the preparation of 1h, 3h-pyrrhol(1,2-c)thiazole-7-carboxamide derivatives - Google Patents

Process for the preparation of 1h, 3h-pyrrhol(1,2-c)thiazole-7-carboxamide derivatives

Info

Publication number
BG51159A3
BG51159A3 BG91500A BG9150090A BG51159A3 BG 51159 A3 BG51159 A3 BG 51159A3 BG 91500 A BG91500 A BG 91500A BG 9150090 A BG9150090 A BG 9150090A BG 51159 A3 BG51159 A3 BG 51159A3
Authority
BG
Bulgaria
Prior art keywords
phenyl
alkyl
phenylalkyl
pyridyl
hydroxyalkyl
Prior art date
Application number
BG91500A
Other languages
English (en)
Inventor
Claude James
Daniel Lave
Francoise Soler
Original Assignee
Rhohe Poulenc Sante
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to BG9284390A priority Critical patent/BG51455A3/xx
Application filed by Rhohe Poulenc Sante filed Critical Rhohe Poulenc Sante
Priority to BG9284490A priority patent/BG50610A3/xx
Publication of BG51159A3 publication Critical patent/BG51159A3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
BG91500A 1989-03-17 1990-03-16 Process for the preparation of 1h, 3h-pyrrhol(1,2-c)thiazole-7-carboxamide derivatives BG51159A3 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
BG9284390A BG51455A3 (en) 1989-03-17 1990-03-06 Process for the preparation derivatives of 1h-3h-pyrol/1,2-c/thiazole-7-carboxamide
BG9284490A BG50610A3 (en) 1989-03-17 1990-03-16 Method for the preparation of derivatives of 1h, 3h- pyrol (1, 2- c) thiazole- 7- carboxamide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8903510A FR2644456B1 (fr) 1989-03-17 1989-03-17 Nouveaux derives du 1h, 3h-pyrrolo(1,2-c)thiazolecarboxamide-7, leur preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
BG51159A3 true BG51159A3 (en) 1993-02-15

Family

ID=9379793

Family Applications (1)

Application Number Title Priority Date Filing Date
BG91500A BG51159A3 (en) 1989-03-17 1990-03-16 Process for the preparation of 1h, 3h-pyrrhol(1,2-c)thiazole-7-carboxamide derivatives

Country Status (24)

Country Link
US (1) US5086051A (fi)
EP (1) EP0388309B1 (fi)
JP (1) JPH02289586A (fi)
KR (1) KR900014408A (fi)
AT (1) ATE102210T1 (fi)
BG (1) BG51159A3 (fi)
CA (1) CA2012343A1 (fi)
CS (2) CS276785B6 (fi)
DD (1) DD297822A5 (fi)
DE (1) DE69006872T2 (fi)
DK (1) DK0388309T3 (fi)
ES (1) ES2062432T3 (fi)
FI (1) FI92069C (fi)
FR (1) FR2644456B1 (fi)
IE (1) IE63313B1 (fi)
IL (1) IL93760A (fi)
MA (1) MA21771A1 (fi)
MX (1) MX26542A (fi)
NO (1) NO172392C (fi)
NZ (1) NZ232960A (fi)
PL (1) PL284321A1 (fi)
PT (1) PT93485B (fi)
TN (1) TNSN90030A1 (fi)
ZA (1) ZA902033B (fi)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW214545B (fi) * 1992-02-17 1993-10-11 Ciba Geigy Ag
US5530141A (en) * 1992-03-04 1996-06-25 Center For Innovative Technology 2,4-diaryl-1,3-dithiolanes; 2,4-diaryl-1,3-dioxolanes; 2,4-diaryl-1,3-oxathiolanes; and 2,5-diaryl-1,3-oxathiolanes for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
US5639782A (en) * 1992-03-04 1997-06-17 Center For Innovative Technology Neolignan derivatives as platelet activating factor receptor antagonists and 5-lipoxygenase inhibitors
US5358938A (en) * 1992-07-13 1994-10-25 Cytomed, Inc. Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
US5648486A (en) * 1992-07-13 1997-07-15 Cytomed, Inc. Compounds and methods for the treatment of inflammatory and immune disorders
US5434151A (en) * 1992-08-24 1995-07-18 Cytomed, Inc. Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
DK0650485T3 (da) 1992-07-13 2001-01-22 Millennium Pharm Inc 2,5-Diaryltetrahydrothiophener, -furaner og analoger til behandling af inflammatoriske forstyrrelser og immunforstyrrelser
US5463083A (en) * 1992-07-13 1995-10-31 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
TW266206B (fi) * 1993-04-28 1995-12-21 Takeda Pharm Industry Co Ltd
US5703093A (en) * 1995-05-31 1997-12-30 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5792776A (en) * 1994-06-27 1998-08-11 Cytomed, Inc., Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5750565A (en) 1995-05-25 1998-05-12 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
DE69701298T2 (de) * 1996-04-15 2000-10-05 Takeda Chemical Industries Ltd Hydroxypyridin-Derivate, ihre Herstellung und ihre pharmazeutische Verwendung
JP5169216B2 (ja) * 2005-08-19 2013-03-27 独立行政法人産業技術総合研究所 色可逆変化表示装置用電極体及びその製造方法、並びに色可逆変化表示装置及び色可逆変化調光装置
WO2009125434A2 (en) * 2008-04-07 2009-10-15 Cadila Healthcare Limited Oxime derivatives
WO2014192023A1 (en) * 2013-05-22 2014-12-04 Cadila Healthcare Limited Novel compounds suitable for the treatment of dyslipidemia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2541280B1 (fr) * 1983-01-13 1985-06-21 Rhone Poulenc Sante Nouveaux derives du 1h, 3h-pyrrolo (1,2c) thiazolecarboxamide-7, leur preparation et les medicaments qui les contiennent
FR2601015B1 (fr) * 1986-07-04 1988-08-05 Rhone Poulenc Sante Nouveaux derives du 1h,3h-pyrrolo (1,2-c) thiazole, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2601016B1 (fr) * 1986-07-04 1988-10-07 Rhone Poulenc Sante Nouveaux derives du 1h,3h-pyrrolo (1,2-c) thiazole, leur preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
CA2012343A1 (fr) 1990-09-17
IL93760A0 (en) 1990-12-23
FI92069C (fi) 1994-09-26
DD297822A5 (de) 1992-01-23
IL93760A (en) 1994-08-26
EP0388309A3 (fr) 1991-07-24
CS276785B6 (en) 1992-08-12
US5086051A (en) 1992-02-04
NO901237L (no) 1990-09-18
FR2644456A1 (fr) 1990-09-21
NZ232960A (en) 1991-02-26
TNSN90030A1 (fr) 1991-03-05
ATE102210T1 (de) 1994-03-15
DK0388309T3 (da) 1994-04-11
MA21771A1 (fr) 1990-10-01
FI92069B (fi) 1994-06-15
DE69006872D1 (de) 1994-04-07
EP0388309B1 (fr) 1994-03-02
EP0388309A2 (fr) 1990-09-19
ES2062432T3 (es) 1994-12-16
CS125290A3 (en) 1992-03-18
NO172392C (no) 1993-07-14
FI901325A0 (fi) 1990-03-16
NO172392B (no) 1993-04-05
NO901237D0 (no) 1990-03-16
IE63313B1 (en) 1995-04-05
MX26542A (es) 1993-09-01
DE69006872T2 (de) 1994-06-30
IE900984L (en) 1990-09-17
ZA902033B (en) 1990-12-28
PT93485B (pt) 1996-02-29
JPH02289586A (ja) 1990-11-29
PL284321A1 (en) 1991-07-29
CS438990A3 (en) 1992-03-18
PT93485A (pt) 1990-11-07
FR2644456B1 (fr) 1991-07-05
KR900014408A (ko) 1990-10-23

Similar Documents

Publication Publication Date Title
BG51159A3 (en) Process for the preparation of 1h, 3h-pyrrhol(1,2-c)thiazole-7-carboxamide derivatives
ES8307806A1 (es) "procedimiento para la preparacion de 1,2-a piridinas y pirazinas".
IL55930A (en) Phenylalkoxydihydroxyoctahydrophenanthrenes,pharmaceutical compositions containing them and intermediates for their preparation
ES472384A1 (es) Un procedimiento para la preparacion de derivados de amino- piridina
YU130584A (en) Process for making 1,4-dihydropyridine
ES8204732A1 (es) Procedimiento de preparacion de derivados de la trimetoxi- 3,4,5 cinamoilpiperacina
ES8600261A1 (es) Un compuesto fenoxi
FR2540870B1 (fi)
ES8601210A1 (es) Procedimiento para la preparacion de nuevos derivados de sinergistinas
FR2570701B1 (fr) Derives de furo(3,2-c)pyridines, leur preparation et leur application en therapeutique
ES8504822A1 (es) Procedimiento para la preparacion de un nuevo derivado del pirrolo ortocondensado
IL61911A (en) 2,3-dihydro-imidazo(1,2-b)pyridazine derivatives,their preparation and pharmaceutical compositions containing them
ES8502981A1 (es) Procedimiento de preparacion de derivados de piperacina.
ZA889285B (en) 2-amino-tetrahydro-isoquinoline derivatives and a process for the preparation thereof and pharmaceutical composition containing same
BG50610A3 (en) Method for the preparation of derivatives of 1h, 3h- pyrol (1, 2- c) thiazole- 7- carboxamide